STOCK TITAN

Chemours names Amy M. Rocklin as next general counsel

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

The Chemours Company (CC) announced a planned transition in its legal leadership. Amy M. Rocklin is set to become senior vice president, general counsel and corporate secretary on January 4, 2027, succeeding Kristine M. Wellman, who plans to retire from the position. Wellman will serve as senior vice president, senior counsel through May 7, 2027.

Rocklin brings more than two decades of legal, business and scientific experience in technology-driven industries. Most recently, she was chief legal and administrative officer and corporate secretary at Neogen Corporation; before that, she spent nearly 10 years at Corning Incorporated, ultimately as vice president, corporate law.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Rocklin's experience More than two decades Legal, business and scientific experience
Rocklin's appointment effective date January 4, 2027 Senior vice president, general counsel and corporate secretary
Wellman's senior counsel role through May 7, 2027 Following the leadership transition
forward-looking statements regulatory
"Forward-looking statements provide current expectations of future events"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who will become Chemours (CC)'s general counsel, and when?

Amy M. Rocklin will take the role on January 4, 2027, succeeding Kristine M. Wellman as senior vice president, general counsel and corporate secretary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001627223 0001627223 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

November 16, 2026

Date of Report (Date of Earliest Event Reported)

 

 

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware 001-36794 46-4845564

(State or Other Jurisdiction

Of Incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

 

1007 Market Street

Wilmington, Delaware, 19801

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (302) 773-1000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered
Common Stock ($0.01 par value)   CC   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On November 18, 2026, The Chemours Company (the “Company”) issued a press release, announcing that Kristine M. Wellman, Senior Vice President, General Counsel & Corporate Secretary, plans to retire from her position, and the Company has selected Amy M. Rocklin to succeed Ms. Wellman as the Company’s Senior Vice President, General Counsel & Corporate Secretary, effective January 4, 2027 (the “Transition Date”). Following the Transition Date, Ms. Wellman will serve as Senior Vice President, Senior Counsel until May 7, 2027.

 

A copy of the press release is furnished hereto as Exhibit 99.1.

 

Item 9.01Financial Statements and Exhibits.

 

(d)       Exhibits.

 

Exhibit No.   Description of Exhibit
99.1   Press Release of the Company, dated as of November 18, 2026.
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

THE CHEMOURS COMPANY  
     
By: /s/ Shane Hostetter  
  Shane Hostetter  
  Senior Vice President, Chief Financial Officer  
     
Date: November 18, 2026  

 

 

 

 

 

Exhibit 99.1 

 

Press Release:

 

The Chemours Company Announces Retirement of Kristine Wellman and Appointment of Amy Rocklin as General Counsel

 

WILMINGTON, Del., Nov. 18, 2026—The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced that Kristine Wellman, Senior Vice President, General Counsel & Corporate Secretary, will retire from Chemours. Concurrent with this change, effective January 4, 2027, Amy Rocklin will join Chemours to serve as Senior Vice President, General Counsel & Corporate Secretary. As part of her transition, effective January 4, 2027, Wellman will move into the role of SVP, Senior Counsel to President and Chief Executive Officer Denise Dignam, where she will continue to provide counsel and support to the Company until May 2027.

 

Wellman joined Chemours in 2014 and has made significant contributions to the Company through a diverse range of leadership roles spanning legal, strategic planning, sustainability and manufacturing operations. She was part of the legal leadership team that helped stand up Chemours as an independent public company and today leads a global team of legal, corporate governance, enterprise risk, compliance, security, sustainability and government affairs professionals.

 

“Kristine has been an extraordinary leader, colleague and trusted advisor, and her impact on Chemours extends well beyond the legal function,” said Denise Dignam, President and Chief Executive Officer of Chemours. “Her breadth of experience, sound judgment and unwavering commitment to integrity have helped shape our company from its earliest days. I am deeply grateful for Kristine’s partnership and many contributions to Chemours, and I am pleased that we will continue to benefit from her experience and counsel during this transition.”

 

Rocklin joins Chemours with more than two decades of legal, business and scientific experience in complex, technology-driven industries. Most recently, she served as Chief Legal & Administrative Officer and Corporate Secretary at Neogen Corporation, where she led global Legal and Compliance and enterprise risk, advised the Board of Directors, and held leadership responsibility for regulatory affairs, quality, government and industry affairs, and sustainability. Prior to Neogen, Rocklin spent nearly 10 years at Corning Incorporated, ultimately serving as Vice President, Corporate Law. She holds a Juris Doctor from The George Washington University Law School and a Ph.D. in Biochemistry, Molecular Biology and Biophysics from the University of Minnesota.

 

“Amy brings a powerful combination of legal expertise, business acumen and scientific and technical understanding to Chemours,” said Dignam. “She has spent her career working at the intersection of law, science, technology and business and understands what it takes to lead in highly regulated global industries. Her experience advising boards and executive teams and navigating complex business and regulatory matters will make her a strong addition to our leadership team. We are excited to welcome Amy and look forward to her leadership and contributions as we execute our Pathway to Thrive strategy and position Chemours for long-term success.”

 

 

 

 

About The Chemours Company


The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn.

 

Forward Looking Statements

 

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words “believe,” “expect,” “will,” “anticipate,” “plan,” “estimate,” “target,” “project” and similar expressions, among others, generally identify “forward-looking statements,” which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the transition of the role of Senior Vice President, General Counsel & Corporate Secretary at Chemours. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, including the ability to complete management transitions. These statements also may involve risks and uncertainties that are beyond Chemours’ control. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our forthcoming Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 and the Annual Report on Form 10-K for the year ended December 31, 2025. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

 

CONTACTS:

 

INVESTORS 
+1.302.773.2263

investor@chemours.com  

 

NEWS MEDIA 
media@chemours.com

 

 

 

 

 

Filing Exhibits & Attachments

4 documents

Keep reading